NASDAQ
Tekla Life Sciences Investors (HQL) has a current ratio of 1.74x as of Monday, May 25, 2026. This represents a 1435.10% increase compared to its 12-month average of 0.11x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.